Floatz logo

Zoladex

Sleep Initiation and Maintenance Disorders

Astellas Pharma IncPhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Sleep Initiation and Maintenance Disorders cohort.

Asset / SponsorPhaseRating
ZOLPIDEM
Astellas Pharma Inc
Phase 3BB
Suvorexant
Merck Sharp & Dohme LLC
Phase 3BB
fk199b
Astellas Pharma Inc
Phase 3BB
Modafinil
VA Palo Alto Health Care System
Phase 4B
Tiaoshen Anti-Cancer Granules
Shanghai Municipal Hospital of Traditional Chinese Medicine
Phase 2/3B

View all 10 →

Same molecule, other indications

Zoladex is also rated in:

HR+/HER2- Breast CancerDormant
BB
Indicative ·
71 / 100
View asset →
prostate neoplasmDormant
BB
Indicative ·
69 / 100
View asset →
prostate adenocarcinomaDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →